Novartis roundup: ITP real-world data completed; three trials registered; Utah study terminatedSep 4Weekly roundup, 6 itemsDDY391inclisiran
Corvus reports Q2 2026 results, updates soquelitinib pipeline progressAug 6Quarterly updateCorvus Pharmaceuticals, Inc.soquelitinib
Sign inSign in